Cargando…

Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis–Related Diabetes

Diabetes is a common and important complication of cystic fibrosis, an autosomal recessive genetic disease due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Cystic fibrosis–related diabetes (CFRD) is associated with profound detrimental effects on the disease c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yoon, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Mini-review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686691/ https://www.ncbi.nlm.nih.gov/pubmed/29264462 http://dx.doi.org/10.1210/js.2017-00362

Ejemplares similares

Animal Models of Preeclampsia: Mechanistic Insights and Promising Therapeutics
por: Taylor, Erin B, et al.
Publicado: (2022)

Update on host-pathogen interactions in cystic fibrosis lung disease
por: Hector, Andreas, et al.
Publicado: (2016)

Evolving Nutritional Needs in Cystic Fibrosis
por: Frantzen, Theresa, et al.
Publicado: (2023)

Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targets
por: Chakraborty, Raja, et al.
Publicado: (2022)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

Mechanistic Causes of Reduced Cardiorespiratory Fitness in Type 2 Diabetes
por: Abushamat, Layla A, et al.
Publicado: (2020)

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
por: Kelsey, Ryan, et al.
Publicado: (2019)

The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2011)

Structural and mechanistic fundamentals for designing of cellulases
por: Marana, Sandro R.
Publicado: (2012)

A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants
por: Sayyed, Sharif Karim, et al.
Publicado: (2023)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

Fungal chitinases: diversity, mechanistic properties and biotechnological potential
por: Hartl, Lukas, et al.
Publicado: (2011)

How many genetic options for evolving insecticide resistance in heliothine and spodopteran pests?
por: Oakeshott, John G, et al.
Publicado: (2013)

Tissue Microarray: A rapidly evolving diagnostic and research tool
por: Jawhar, Nazar M.T.
Publicado: (2009)

Senotherapeutics: emerging strategy for healthy aging and age-related disease
por: Kim, Eok-Cheon, et al.
Publicado: (2019)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

Beta‐cell replacement strategies for diabetes
por: Kieffer, Timothy J, et al.
Publicado: (2017)

Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies
por: Anand, Akshay, et al.
Publicado: (2015)

The emergence of AntibodyPlus: the future trend of antibody-based therapeutics
por: Zhu, Yong, et al.
Publicado: (2022)

Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
por: Almughem, Fahad A., et al.
Publicado: (2020)

Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Chirgwin, Michael E., et al.
Publicado: (2019)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

A potential therapeutic strategy for prostatic disease by targeting the oral microbiome
por: Fang, Cheng, et al.
Publicado: (2020)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
por: Roehlen, Natascha, et al.
Publicado: (2020)

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID
por: Narayanan, J., et al.
Publicado: (2023)

Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection
por: Kumar, Rajesh, et al.
Publicado: (2020)

Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
por: Jovanovic, Aleksandar, et al.
Publicado: (2014)

Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
por: Pinzaru, Anca Daniela, et al.
Publicado: (2023)

Role of HIPK2 in kidney fibrosis
por: Fan, Ying, et al.
Publicado: (2014)

Cystic Fibrosis-Related Diabetes
por: Kayani, Kayani, et al.
Publicado: (2018)

A view of acidic intracellular compartments
Publicado: (1988)

Mechanisms of iron homeostasis in Pseudomonas aeruginosa and emerging therapeutics directed to disrupt this vital process
por: Sánchez‐Jiménez, Ana, et al.
Publicado: (2023)

Evolving concepts in extra-articular hip pathology
por: Martin, Hal D.
Publicado: (2015)

Strategies for the etiological therapy of cystic fibrosis
por: Maiuri, Luigi, et al.
Publicado: (2017)

Fibrosis and renal aging
por: Yang, Hai-Chun, et al.
Publicado: (2014)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
por: Hasan, Sana, et al.
Publicado: (2022)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes
por: Al-Selwi, Yara, et al.
Publicado: (2021)

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)

Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies
por: Akash, Muhammad Sajid Hamid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_usnv2g6b6rq5tl362fp2ne8tvr